Susquehanna International Group’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-27,201
Closed -$17K 11259
2020
Q1
$17K Buy
27,201
+3,637
+15% +$2.78K ﹤0.01% 9973
2019
Q4
$18K Buy
23,564
+7,784
+49% +$5.31K ﹤0.01% 9501
2019
Q3
$10K Sell
15,780
-7,146
-31% -$5.85K ﹤0.01% 10022
2019
Q2
$22K Buy
22,926
+7,626
+50% +$7.49K ﹤0.01% 9997
2019
Q1
$17K Buy
+15,300
New +$17.3K ﹤0.01% 8613
2018
Q3
Sell
-17,412
Closed -$20K 10566
2018
Q2
$20K Buy
+17,412
New +$18.6K ﹤0.01% 9429
2017
Q4
Sell
-36,309
Closed -$17K 10138
2017
Q3
$17K Buy
+36,309
New +$18.9K ﹤0.01% 8661
2016
Q3
Sell
-10,469
Closed -$5K 9264
2016
Q2
$5K Sell
10,469
-21,197
-67% -$8.63K ﹤0.01% 8442
2016
Q1
$12K Buy
+31,666
New +$12.8K ﹤0.01% 8867
2015
Q2
Sell
-19,495
Closed -$19K 10595
2015
Q1
$19K Buy
+19,495
New +$35.9K ﹤0.01% 9281

Other funds holding BDR

Susquehanna International Group's BDR Position: Q2 2020 in Review

Susquehanna International Group sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2020, closing a stake of 27,201 shares — an estimated $17K sold.

Susquehanna International Group first reported a position in BDR in Q1 2015 and held it in 10 quarters. The position peaked at $22K in Q2 2019. 6 funds tracked by Wall St. Rank hold BDR as of Q2 2020.

  • Susquehanna International Group reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2020 after selling out during the quarter.
  • Susquehanna International Group sold 27,201 Blonder Tongue Laboratories Inc shares in Q2 2020, an estimated $17K.
  • Susquehanna International Group first reported a position in Blonder Tongue Laboratories Inc in Q1 2015 and held it in 10 quarters.
  • Susquehanna International Group's Blonder Tongue Laboratories Inc position peaked at $22K in Q2 2019.
  • 6 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.